Efficacy and Safety of Qili Qiangxin Capsule on Dilated Cardiomyopathy: A Systematic Review and Meta-Analysis of 35 Randomized Controlled Trials

Efficacy and Safety of Qili Qiangxin Capsule on Dilated Cardiomyopathy: A Systematic Review and Meta-Analysis of 35 Randomized Controlled Trials

Objective: Qili Qiangxin Capsule (QQC), a Chinese patent medicine, is clinically effective in treating dilated cardiomyopathy (DCM). However, the meta-analysis of QCC combined with conventional western medicine (CWM) on DCM remains unexplored. This study aimed to systematically evaluate the efficacy...

Full description

Bibliographic Details
Main Authors: Jingjing Wei, Bin Li, Xinlu Wang, Xingyuan Li, Yucai Hu, Lijie Qiao, Cheng Zhou, Peng Yu, Tianqing Sang, Mingjun Zhu, Yongxia Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Pharmacology
Subjects:
Qili Qiangxin capsule
dilated cardiomyopathy
randomized controlled trials
meta-analysis
grade
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.893602/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.893602/full

Similar Items